Iradimed Co (NASDAQ:IRMD) — Market Cap & Net Worth
Market Cap & Net Worth: Iradimed Co (IRMD)
Iradimed Co (NASDAQ:IRMD) has a market capitalization of $1.16 Billion ($1.16 Billion) as of August 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #8145 globally and #2395 in its home market, demonstrating a -3.20% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Iradimed Co's stock price $90.86 by its total outstanding shares 12783035 (12.78 Million). See Iradimed Co (IRMD) capital reinvestment to understand how much of operating cash flow is reinvested back into capital assets.
Iradimed Co Market Cap History: 2015 to 2026
Iradimed Co's market capitalization history from 2015 to 2026. Data shows growth from $332.74 Million to $1.16 Billion (12.63% CAGR).
Index Memberships
Iradimed Co is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.46 Trillion | 0.05% | #235 of 976 |
|
NASDAQ Composite
IXIC
|
$40.26 Trillion | 0.00% | #893 of 3165 |
Weight: Iradimed Co's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Iradimed Co Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Iradimed Co's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
14.84x
Iradimed Co's market cap is 14.84 times its annual revenue
Latest Price to Earnings (P/E) Ratio
55.32x
Iradimed Co's market cap is 55.32 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $131.77 Million | $32.50 Million | $7.21 Million | 4.05x | 18.26x |
| 2017 | $179.84 Million | $23.08 Million | $499.76K | 7.79x | 359.86x |
| 2018 | $290.36 Million | $30.44 Million | $6.30 Million | 9.54x | 46.06x |
| 2019 | $277.54 Million | $38.52 Million | $9.63 Million | 7.21x | 28.82x |
| 2020 | $270.66 Million | $31.72 Million | $1.37 Million | 8.53x | 197.70x |
| 2021 | $548.55 Million | $41.81 Million | $9.33 Million | 13.12x | 58.82x |
| 2022 | $342.68 Million | $53.30 Million | $12.83 Million | 6.43x | 26.71x |
| 2023 | $600.97 Million | $65.56 Million | $17.19 Million | 9.17x | 34.95x |
| 2024 | $703.07 Million | $73.24 Million | $19.23 Million | 9.60x | 36.55x |
| 2025 | $1.24 Billion | $83.81 Million | $22.48 Million | 14.84x | 55.32x |
Competitor Companies of IRMD by Market Capitalization
Companies near Iradimed Co in the global market cap rankings as of August 3, 2026.
Key companies related to Iradimed Co by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $183.80 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #189 globally with a market cap of $124.64 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #238 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $183.80 Billion | $105.70 |
| #189 | Stryker Corporation | NYSE:SYK | $124.64 Billion | $325.70 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #238 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $85.39 |
Iradimed Co Historical Marketcap From 2015 to 2026
Between 2015 and today, Iradimed Co's market cap moved from $332.74 Million to $ 1.16 Billion, with a yearly change of 12.63%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.16 Billion | -6.60% |
| 2025 | $1.24 Billion | +76.87% |
| 2024 | $703.07 Million | +16.99% |
| 2023 | $600.97 Million | +75.37% |
| 2022 | $342.68 Million | -37.53% |
| 2021 | $548.55 Million | +102.68% |
| 2020 | $270.66 Million | -2.48% |
| 2019 | $277.54 Million | -4.42% |
| 2018 | $290.36 Million | +61.45% |
| 2017 | $179.84 Million | +36.49% |
| 2016 | $131.77 Million | -60.40% |
| 2015 | $332.74 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of Iradimed Co was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.16 Billion USD |
| MoneyControl | $1.16 Billion USD |
| MarketWatch | $1.16 Billion USD |
| marketcap.company | $1.16 Billion USD |
| Reuters | $1.16 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Iradimed Co
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs moni… Read more